Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...

In Vitro Drug Dissolution: Compendial Testing Models II

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...

In Vitro Drug Dissolution: Compendial Testing Models I

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: <i>In Vitro</i> BBB triculture assay and preliminary computational model development to predict brain exposure.

Frontiers in toxicology·2026

Same author

<i>In Vitro</i> BBB triculture assay and preliminary computational model development to predict brain exposure.

Frontiers in toxicology·2026

Same author

LAP-Hsp60 complex modulates epithelial tight junction barrier.

Research square·2025

Same author

From Unwanted Annoyances to Oral Delivery Saviors: The Rollercoaster Journey of Amorphous Drugs.

Molecular pharmaceutics·2025

Same author

Evaluation of potency and metabolic stability of diphyllin-derived Vacuolar-ATPase inhibitors.

European journal of medicinal chemistry·2024

Same author

Structural features of the glassy state and their impact on the solid-state properties of organic molecules in pharmaceutical systems.

Journal of pharmaceutical sciences·2024

Search research articles

Related Experiment Video

Updated: May 26, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

Assessing the performance of amorphous solid dispersions.

Ann Newman¹, Gregory Knipp, George Zografi

¹Seventh Street Development Group, Lafayette, Indiana 47901, USA. ann.newman@seventhstreetdev.com

Journal of Pharmaceutical Sciences

|January 4, 2012

Summary

This summary is machine-generated.

Stable amorphous solid dispersions significantly enhance active pharmaceutical ingredient (API) bioavailability in most cases. Key factors influencing performance include in vitro dissolution and in vivo physiological conditions.

More Related Videos

Dispersion of Nanomaterials in Aqueous Media: Towards Protocol Optimization

Dispersion of Nanomaterials in Aqueous Media: Towards Protocol Optimization

Published on: December 25, 2017

Formation of Dispersible Taohong Siwu Tablets

Formation of Dispersible Taohong Siwu Tablets

Published on: February 3, 2023

Related Experiment Videos

Last Updated: May 26, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

Dispersion of Nanomaterials in Aqueous Media: Towards Protocol Optimization

Dispersion of Nanomaterials in Aqueous Media: Towards Protocol Optimization

Published on: December 25, 2017

Formation of Dispersible Taohong Siwu Tablets

Formation of Dispersible Taohong Siwu Tablets

Published on: February 3, 2023

Area of Science:

Pharmaceutical Sciences
Drug Delivery Systems
Materials Science

Background:

Amorphous solid dispersions (ASDs) are crucial for improving the bioavailability of poorly soluble drugs.
Evaluating the performance of ASDs requires understanding numerous influencing factors.

Purpose of the Study:

To systematically review and analyze 40 research papers on ASDs.
To identify key factors affecting the dissolution and bioavailability of active pharmaceutical ingredients (APIs) from ASDs.

Main Methods:

Meta-analysis of published data on ASDs.
Comparative analysis of in vitro and in vivo variables reported in the literature.
Categorization of ASD performance based on bioavailability enhancement.

Main Results:

Approximately 82% of reviewed ASDs demonstrated improved bioavailability.
About 8% showed lower bioavailability, and 10% showed similar bioavailability compared to reference materials.
Significant variations in in vitro (dissolution media, agitation, particle size) and in vivo (animal models, fed/fasted state) factors were identified.

Conclusions:

ASDs are highly effective for enhancing drug bioavailability, but performance is sensitive to experimental conditions.
Recommendations are provided for assessing physical stability and considering GI physiological factors for accurate ASD performance evaluation.